Overview
- 9 FDA inspections are on record.
- 4 inspections produced a Form 483.
- The most recent recorded inspection date is 2023-05-11.
At a glance
Inspections
9
Form 483s
4
EIRs
2
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 10 May 2023 – 11 May 2023 | Medical Devices & Rad Health | 483 | View 483 → |
| 13 Feb 2023 – 16 Feb 2023 | Human Drugs | Clean | |
| 13 Jun 2022 – 23 Jun 2022 | Human Drugs | 483 | View 483 → |
| 28 Jan 2015 – 3 Feb 2015 | Human Drugs | Clean | |
| 2 Apr 2012 | Not recorded | Clean | |
| 11 May 2010 | Not recorded | 483 | View 483 → |
| 22 Aug 2008 | Not recorded | 483 | On file |
| 11 Mar 2005 | Not recorded | Clean | |
| 5 Feb 2003 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
Investigators
FDA investigators tied to this site in the record.
Joanne E King4 insp.
Ronald Ifraimov1 insp.
Adam R Cooke1 insp.
Ariel Cruz Figueroa1 insp.
Kevin T Nguyen1 insp.
Jennifer Lalama1 insp.
Rachel Gomez1 insp.
Richard A Lyght1 insp.
Marie F Morin1 insp.
Sarah E Mcmullen1 insp.
Rebecca Rodriguez1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 803.50(a)(1) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind USpharma Ltd's 4 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat